Columbus Circle Investors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Columbus Circle Investors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-418,545	Closed	-$5.14M	–	227
2017 Q3	$5.14M	Sell	418,545 -266,588	-39%	-$3.94M	0.09%	170
2017 Q2	$11.3M	Sell	685,133 -11,646	-2%	-$180K	0.19%	120
2017 Q1	$9.99M	Sell	696,779 -55,400	-7%	-$822K	0.14%	149
2016 Q4	$10.4M	Sell	752,179 -293,909	-28%	-$4.72M	0.14%	141
2016 Q3	$18.9M	Buy	1,046,088 +551,766	+112%	+$8.88M	0.2%	103
2016 Q2	$7.09M	Sell	494,322 -100,020	-17%	-$1.36M	0.07%	195
2016 Q1	$7.1M	Sell	594,342 -163,994	-22%	-$1.72M	0.06%	201
2015 Q4	$10.1M	Buy	+758,336	New	+$9.32M	0.08%	199

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

Columbus Circle Investors's LXRX Position: Q4 2017 in Review

Columbus Circle Investors sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2017, closing a stake of 418,545 shares — an estimated $5.14M sold.

Columbus Circle Investors first reported a position in LXRX in Q4 2015 and held it in 8 quarters. The position peaked at $18.9M in Q3 2016. 133 funds tracked by Wall St. Rank hold LXRX as of Q4 2017.

Columbus Circle Investors reported no remaining Lexicon Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Columbus Circle Investors sold 418,545 Lexicon Pharmaceuticals shares in Q4 2017, an estimated $5.14M.
Columbus Circle Investors first reported a position in Lexicon Pharmaceuticals in Q4 2015 and held it in 8 quarters.
Columbus Circle Investors's Lexicon Pharmaceuticals position peaked at $18.9M in Q3 2016.
133 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.